|
C17ORF42 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.222800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.427900E-04 |
| Normal-vs-Stage2 |
3.798200E-02 |
| Normal-vs-Stage3 |
8.523800E-01 |
| Normal-vs-Stage4 |
5.918200E-01 |
| Stage1-vs-Stage2 |
7.690000E-01 |
| Stage1-vs-Stage3 |
8.032100E-02 |
| Stage1-vs-Stage4 |
4.907200E-01 |
| Stage2-vs-Stage3 |
1.033040E-01 |
| Stage2-vs-Stage4 |
4.139600E-01 |
| Stage3-vs-Stage4 |
6.755000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.592500E-04 |
| Normal-vs-AfricanAmerican |
3.217500E-02 |
| Normal-vs-Asian |
1.062690E-03 |
| Caucasian-vs-AfricanAmerican |
6.100400E-01 |
| Caucasian-vs-Asian |
4.678000E-01 |
| AfricanAmerican-vs-Asian |
3.565800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.220900E-04 |
| Normal-vs-Female |
1.360470E-02 |
| Male-vs-Female |
7.941600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.944800E-01 |
| Normal-vs-Extreme_Weight |
9.959400E-03 |
| Normal-vs-Obese |
1.107610E-01 |
| Normal-vs-Extreme_Obese |
9.091800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.181400E-01 |
| Normal_Weight-vs-Obese |
5.515000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.608200E-02 |
| Extreme_Weight-vs-Obese |
5.331200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.420400E-01 |
| Obese-vs-Extreme_Obese |
1.633210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.005780E-01 |
| Normal-vs-Age(41-60Yrs) |
8.03719999999952E-05 |
| Normal-vs-Age(61-80Yrs) |
5.838900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.935800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.374000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.885400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.326300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.072200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.873520E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.341900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.27350000439708E-08 |
| Normal-VS-Type2 PRCC |
7.764800E-01 |
| Normal-VS-KIRP CIMP |
6.880000E-01 |
| Normal-VS-Unclassified PRCC |
1.714980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.15219999999405E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.974470E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.253600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.282000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.567800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.911560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.972300E-02 |
| Normal-vs-N1 |
2.800400E-01 |
| Normal-vs-N2 |
3.958800E-04 |
| N0-vs-N1 |
7.839000E-01 |
| N0-vs-N2 |
1.969780E-02 |
| N1-vs-N2 |
1.690210E-02 |
|
|
